Article IP Patent Infringement Patent Prosecution 
IP Watchdog
MARCH 13, 2022
The United States Patent and Trademark Office (USPTO) announced last week that it will terminate engagement with the Russian IP Office (Rospatent) as well as the Eurasian Patent Organization (EAPO) and the IP Office of Belarus, which has been cooperating with Russia in the lead-up to and during the Russian invasion of Ukraine.
IPilogue
SEPTEMBER 13, 2021
Bonnie Hassanzadeh is an IP Intensive student and 3L JD Candidate at Osgoode Hall Law School. As part of the IP Innovation Clinic’s involvement in the inaugural year of Mitacs’ Business Strategy Internship program, Bonnie completed an internship at Bereskin & Parr LLP under the direct supervision of Reshika Dhir.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
IP Watchdog
NOVEMBER 1, 2023
Specifically, the CAFC said the district court erred by relying heavily on the patent prosecution history statements for a related patent that had been cited in the information disclosure statement (IDS) during supplemental examination of one of the patents-in-suit to inform its construction of the term in question.
IP Watchdog
SEPTEMBER 2, 2021
for infringement of the ‘197 patent under the Hatch-Waxman Act, but the district court found that the Belcher Chief Science Officer withheld material information from the U.S. Patent and Trademark Office (USPTO) during patent prosecution, and the CAFC affirmed. Belcher brought the suit against Hospira, Inc.
IP Watchdog
JUNE 27, 2024
Patent and Trademark Office (USPTO) issued a draft Request for Comments (RFC) today seeking public feedback “on the current state of the experimental use exception jurisprudence and whether legislative action should be considered to enact a statutory experimental use exception.” According to the RFC, since the U.S.
Fish & Richardson Trademark & Copyright Thoughts
DECEMBER 2, 2020
As with any growing industry, cannabis stakeholders are eager to protect their valuable intellectual property (IP) rights, but their ability to obtain comprehensive IP protection and enforce their IP rights is sometimes in conflict with federal drug law. Patent Prosecution. FDA Regulation.
IP Watchdog
MAY 31, 2022
Both AR and VR will undoubtedly bring a whole set of novel IP issues for individuals, companies, IP practitioners and the courts. Augmented Reality (“AR”), along with Virtual Reality (“VR”), is rapidly growing in prominence and will be transformative to the way we live, work, learn and play.
Expert insights. Personalized for you.
105 
Let's personalize your content